Home
Drugs
Carboplatin
Clinical Trials

Clinical Trials Related to Carboplatin

Related studies linked through entity extraction aliases.

Efficacy and Safety Study of First-line Treatment With SG001 Plus Chemotherapy ± Bevacizumab Versus Placebo Plus Chemotherapy ±Bevacizumab for Recurrent, or Metastatic Cervical Cancer With PD-L1 Positive (CPS≥1)

Status: NOT_YET_RECRUITING
Phase: PHASE3

Immune Profile Selection By Fraction of ctDNA in Patients With Advanced NSCLC Treated With Immunotherapy

Status: RECRUITING
Phase: PHASE2

A Trial Comparing Chemotherapy Versus Novel Immune Checkpoint Inhibitor (Pembrolizumab) Plus Chemotherapy in Treating Relapsed/Refractory Classical Hodgkin Lymphoma

Status: WITHDRAWN
Phase: PHASE3

A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer

Status: RECRUITING
Phase: EARLY_PHASE1

Pemetrexed-free vs. Pemetrexed-based Immunochemotherapy in Metastatic TTF-1 Negative Lung Adenocarcinoma

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE4

Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic Alterations

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

DUMAS: Neo-Adjuvant Immunotherapy for Pancoast Tumors

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

JS004 Combined With Toripalimab and With Standard Chemotherapy Treat Patients With Advanced Lung Cancer

Status: COMPLETED
Phase: PHASE1/PHASE2

A Safety and Efficacy Study of Bevacizumab, Paclitaxel, Carboplatin Compared to Avastin® in Non-Small Cell Lung Cancer

Status: RECRUITING
Phase: PHASE3

Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Pyrotinib Combined With Trastuzumab, Dalpiciclib, Letrozole Versus TCbHP (Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin) as Neoadjuvant Treatment in HR +/HER2 + Breast Cancer

Status: RECRUITING
Phase: PHASE2

Study of AK119 and AK112 With or Without Chemotherapy for NSCLC Patients

Status: TERMINATED
Phase: PHASE1/PHASE2

A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Study of Novel Treatment Combinations in Patients With Lung Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Status: RECRUITING
Phase: PHASE3

Neoadjuvant of Tislelizumab Combined With Chemotherapy Followed by Surgery in Unresectable Stage Ⅲ NSCLC

Status: RECRUITING
Phase: PHASE2

Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Study to Evaluate Adverse Events, Change in Disease Activity, and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab, Cisplatin, or Carboplatin in Adult Participants With Advanced Solid Tumors

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

Patient-reported Outcomes in Preoperative Immunochemotherapy/Radiotherapy-treated Esophageal Cancer Patients

Status: UNKNOWN
Phase: PHASE2

Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1